Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial-Reference-Cited by-同舟云学术

Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial

Published:2022-10 Issue:10 Volume:10 Page:e1485-e1493
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Baisley Kathy,Kemp Troy J,Kreimer Aimée R,Basu Partha,Changalucha John,Hildesheim Allan,Porras Carolina,Whitworth Hilary,Herrero Rolando,Lacey Charles J,Schiller John T,Lucas Eric,Mutani Paul,Dillner Joakim,Indangasi Jackton,Muwonge Richard,Hayes Richard J,Pinto Ligia A,Watson-Jones Deborah

Publisher

Elsevier BV

Subject

General Medicine

Reference27 articles.

1. Global strategy to accelerate the elimination of cervical cancer as a public health problem,2020

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

3. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019;Bruni;Prev Med,2021

4. Use of a 2-dose schedule for human papillomavirus vaccination - updated recommendations of the Advisory Committee on Immunization Practices;Meites;MMWR Morb Mortal Wkly Rep,2016

5. Status of HPV vaccine introduction and barriers to country uptake;Gallagher;Vaccine,2018

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control;Viruses;2024-08-25

2. Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: An updated systematic review of evidence from clinical trials;Vaccine: X;2024-08

3. Immunogenicity and Safety of Extended-Interval 2-Dose Regimens of 9vHPV Vaccine;Pediatrics;2024-07-09

4. The deadlock on HPV vaccination in Japan is almost broken!;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-06

5. Safety and immunogenicity of Innovax bivalent human papillomavirus vaccine in girls 9–14 years of age: Interim analysis from a phase 3 clinical trial;Vaccine;2024-04